EPO Issues Notice of Intent to Grant Alnylam Patent Covering siRNA Modifications

The chemical modifications are "broadly used to achieve potency, stability, and selectivity of siRNAs; features that are needed to design siRNAs with drug-like properties for therapeutic applications," the company noted.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.